These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 6939880)
41. Toxicity to D-penicillamine in rheumatoid arthritis. Magnus JH; Gran JT; Mikkelsen K; Nygaard H; Brath HK Scand J Rheumatol; 1987; 16(6):441-4. PubMed ID: 2962277 [No Abstract] [Full Text] [Related]
42. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine. Capell HA; Maiden N; Madhok R; Hampson R; Thomson EA J Rheumatol; 1998 Oct; 25(10):1880-6. PubMed ID: 9779839 [TBL] [Abstract][Full Text] [Related]
43. [Zinc levels in blood and urine of rheumatoid arthritis patients after four months treatment with D-penicillamine]. Teherani DK; Altmann H; Tausch G; Eberl R Z Rheumatol; 1980; 39(11-12):395-400. PubMed ID: 7282103 [TBL] [Abstract][Full Text] [Related]
44. [D-penicillamine-induced myasthenia gravis]. Frey RA; Keller F; Michel BA Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208 [TBL] [Abstract][Full Text] [Related]
45. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes]. Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305 [TBL] [Abstract][Full Text] [Related]
50. Penicillamine in rheumatoid disease: a long-term study. Day AT; Golding JR; Lee PN; Butterworth AD Br Med J; 1974 Feb; 1(5900):180-3. PubMed ID: 4590670 [TBL] [Abstract][Full Text] [Related]
51. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis. Wysocka K; Fabian F; Listewnik M Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112 [TBL] [Abstract][Full Text] [Related]
53. Effect of oral zinc sulphate and penicillamine on zinc metabolism in patients with rheumatoid arthritis. Kennedy AC; Bessent RG; Reynolds PM J Rheumatol; 1980; 7(5):639-44. PubMed ID: 7441655 [TBL] [Abstract][Full Text] [Related]
54. Clinical efficacy and adverse effects of tiopronin in rheumatoid arthritis. Report of a follow-up in 50 patients. Ambanelli U; Manganelli P; Ferraccioli GF Z Rheumatol; 1982; 41(5):235-9. PubMed ID: 7158085 [TBL] [Abstract][Full Text] [Related]
55. Pyrithioxine and thiopronine: new penicillamine-like drugs in rheumatoid arthritis. Camus JP; Crouzet J; Prier A; Bergevin H J Rheumatol Suppl; 1981; 7():175-7. PubMed ID: 6939882 [TBL] [Abstract][Full Text] [Related]
56. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine? Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051 [TBL] [Abstract][Full Text] [Related]
57. Nursing care of outpatients taking penicillamine as a trial drug in the treatment of rheumatoid arthritis. Langstaff SR Nurs Times; 1975 Jun; 71(24):920. PubMed ID: 1134976 [No Abstract] [Full Text] [Related]
58. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis. Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508 [TBL] [Abstract][Full Text] [Related]
59. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy. Pickup ME; Dixon JS; Lowe JR; Wright V J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471 [TBL] [Abstract][Full Text] [Related]
60. Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis. Tishler M; Kahn Y; Yaron M Ann Rheum Dis; 1991 Apr; 50(4):255-6. PubMed ID: 1903031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]